EMA Survey To Gauge Pharma's Satisfaction With Its Medical Literature Monitoring Service
This article was originally published in SRA
Executive Summary
The European Medicines Agency is inviting feedback from pharmaceutical companies using its medical literature monitoring service to gauge if they are satisfied with the operation of this new tool, which was created under the provisions of the EU pharmacovigilance legislation to reduce the administrative burden on companies1.